v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Conversion of Convertible Notes
Common stock
Common stock
Conversion of Convertible Notes
Additional paid in capital
Additional paid in capital
Conversion of Convertible Notes
Acc. other comprehensive (loss) income
Treasury stock
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024     251,554,378            
Beginning balance at Dec. 31, 2024 $ (3,714)   $ 26   $ 625,130   $ 121 $ (57,350) $ (571,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (290,605)               (290,605)
Foreign currency translation adjustments (270)           (270)    
Unrealized losses on available for sale investments, net 0                
Equity-based compensation expense 11,719       11,719        
Exercise of options (in shares)     1,125,214            
Exercise of options 1,633       1,633        
Issuance of shares for paid-in-kind interest on 2029 Notes (in shares)     1,084,119            
Issuance of shares for paid-in-kind interest on 2029 Notes 4,095       4,095        
Issuance of shares for equity-based compensation awards, net tax settlements (in shares)     6,124,374            
Issuance of shares for equity-based compensation awards, net of tax settlements (1,679)   $ 2   (1,681)        
Issuance of shares from at-the-market offering (in shares)     77,253,313            
Issuance of shares from at-the-market offering 294,750   $ 8   294,742        
Issuance of shares purchased under ESPP (in shares)     571,875            
Issuance of shares purchased under ESPP 1,069       1,069        
Proceeds from exercise of warrants (in shares)     14,800,000            
Proceeds from exercise of warrants 113,953   $ 1   113,952        
Issuance of shares for exercised convertible notes (in shares)       16,658,335          
Issuance of shares upon conversion of 2029 Notes   $ 135,599   $ 2   $ 135,597      
Ending balance (in shares) at Jun. 30, 2025     369,171,608            
Ending balance at Jun. 30, 2025 266,550   $ 39   1,186,256   (149) (57,350) (862,246)
Beginning balance (in shares) at Mar. 31, 2025     289,052,369            
Beginning balance at Mar. 31, 2025 197,795   $ 31   888,608   133 (57,350) (633,627)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (228,619)               (228,619)
Foreign currency translation adjustments (282)           (282)    
Unrealized losses on available for sale investments, net 0                
Equity-based compensation expense 4,319       4,319        
Exercise of options (in shares)     141,780            
Exercise of options 240       240        
Issuance of shares for paid-in-kind interest on 2029 Notes (in shares)     1,084,119            
Issuance of shares for paid-in-kind interest on 2029 Notes 4,095       4,095        
Issuance of shares for equity-based compensation awards, net tax settlements (in shares)     3,004,152            
Issuance of shares for equity-based compensation awards, net of tax settlements (362)       (362)        
Issuance of shares from at-the-market offering (in shares)     75,317,313            
Issuance of shares from at-the-market offering 288,295   $ 8   288,287        
Issuance of shares purchased under ESPP (in shares)     571,875            
Issuance of shares purchased under ESPP 1,069       1,069        
Ending balance (in shares) at Jun. 30, 2025     369,171,608            
Ending balance at Jun. 30, 2025 $ 266,550   $ 39   1,186,256   (149) (57,350) (862,246)
Beginning balance (in shares) at Dec. 31, 2025 436,955,655   436,955,655            
Beginning balance at Dec. 31, 2025 $ 611,870   $ 46   1,534,792   (63) (57,350) (865,555)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (82,512)               (82,512)
Foreign currency translation adjustments 143           143    
Unrealized losses on available for sale investments, net (1,023)           (1,023)    
Equity-based compensation expense $ 8,166       8,166        
Exercise of options (in shares) 43,430   43,430            
Exercise of options $ 80       80        
Issuance of shares for equity-based compensation awards, net tax settlements (in shares)     4,110,012            
Issuance of shares for equity-based compensation awards, net of tax settlements (1,347)       (1,347)        
Issuance of shares purchased under ESPP (in shares)     315,409            
Issuance of shares purchased under ESPP 1,590       1,590        
Issuance of shares for exercised convertible notes (in shares)       38,069,987          
Issuance of shares upon conversion of 2029 Notes   $ 233,357   $ 3   $ 233,354      
Retirement of treasury stock $ 0       (57,350)     57,350  
Ending balance (in shares) at Jun. 30, 2026 479,494,493   479,494,493            
Ending balance at Jun. 30, 2026 $ 770,324   $ 49   1,719,285   (943) 0 (948,067)
Beginning balance (in shares) at Mar. 31, 2026     477,014,064            
Beginning balance at Mar. 31, 2026 790,405   $ 49   1,713,437   (763) 0 (922,318)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (25,749)               (25,749)
Foreign currency translation adjustments 25           25    
Unrealized losses on available for sale investments, net (205)           (205)    
Equity-based compensation expense 4,743       4,743        
Exercise of options (in shares)     6,941            
Exercise of options 13       13        
Issuance of shares for equity-based compensation awards, net tax settlements (in shares)     2,158,079            
Issuance of shares for equity-based compensation awards, net of tax settlements (498)       (498)        
Issuance of shares purchased under ESPP (in shares)     315,409            
Issuance of shares purchased under ESPP $ 1,590       1,590        
Ending balance (in shares) at Jun. 30, 2026 479,494,493   479,494,493            
Ending balance at Jun. 30, 2026 $ 770,324   $ 49   $ 1,719,285   $ (943) $ 0 $ (948,067)